March 26, 2003
AmeriSource Health Services Has
Recalled Estrace Tablets
The Food and Drug
Administration (FDA) has released the following information.
Estrace Tablets (estradiol tablets, USP), 2 mg, bottles of 100 tablets, Rx
only. Recall # D-180-3.
Lots: #011137, Exp. APR 16 03;
#011780, Exp. JUN 23 03;
#011851, Exp. JUL 06 03; and
#012022, Exp. AUG 29 03.
Recalling Firm: AmeriSource Health Services Corp., Columbus, OH, by letters
on February 19, 2003.
Manufacturer: Bristol-Myers Squibb Co., Princeton, NJ. Firm initiated recall
Dissolution Failure: by manufacturer (Bristol-Myers Squibb).
VOLUME OF PRODUCT IN COMMERCE